MedTrace Logo

Critical Illness After Hematopoietic Cell Transplantation

NCT07328724 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 4000

Last updated 2026-01-09

No results posted yet for this study

Summary

This is a prospective, multicenter observational trial for patients who develop critical illness after hematopoietic cell transplantation. Patients who are admitted to the intensive care unit after undergoing hematopoietic cell transplantation at the participating medical centers will be enrolled in this study. The clinical characteristics, laboratory profiles, managements, and clinical outcomes will be prospectively collected.

Conditions

  • Critical Illness
  • Ventilated Patients
  • Hematopoetic Stem Cell Transplantation
  • Transplant Complication

Sponsors & Collaborators

  • Hematology Hospital of Chinese Academy of Medical Sciences (Hematology Research Center of Chinese Academy of Medical Sciences)

    collaborator UNKNOWN

  • Xinqiao hospital of the third military medical university

    collaborator UNKNOWN

  • First Affiliated Hospital of Zhejiang University

    collaborator OTHER

  • First Affiliated Hospital of Harbin Medical University

    collaborator OTHER

  • Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

    collaborator OTHER

  • Peking University People's Hospital

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-01-01
Primary Completion
2036-06-30
Completion
2036-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07328724 on ClinicalTrials.gov